B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment

Journal:

Annals of the Rheumatic Diseases

Published:

2025-12-06

DOI:

10.1016/j.ard.2025.11.015

Affiliations:

37

Authors:

35

Go to article

Institutions	Authors	Share
Novartis, Switzerland	3.000000	0.09
Renji Hospital, SJTU, China	1.000000	0.03
Hôpital Haut-Lévêque, France	1.000000	0.03
V.A. Nasonova Research Institute of Rheumatology, Russia	1.000000	0.03
Hospital de la Santa Creu i Sant Pau, Spain	1.000000	0.03
Dr Jan Biziel's University Hospital No. 2, Poland	1.000000	0.03
Vall d'Hebron University Hospital (HUVH), ICS, Spain	1.000000	0.03
Charles University (CU), Czech Republic	1.000000	0.03
Faculty of Medicine Siriraj Hospital, MU, Thailand	1.000000	0.03
China Medical University Hospital (CMUH), Taiwan	1.000000	0.03
Sergei Kirov Military Medical Academy, Russia	1.000000	0.03
Phramongkutklao Hospital, Thailand	1.000000	0.03
Japan Community HealthCare Organization Chukyo Hospital, Japan	1.000000	0.03
Sun Yat-sen Memorial Hospital, SYSU, China	1.000000	0.03
Medical University of Warsaw (MUW), Poland	1.000000	0.03
St. Luke's International Hospital, Japan	1.000000	0.03
Organización Médica de Investigación (OMI), Argentina	1.000000	0.03
Taichung Veterans General Hospital, Taiwan	1.000000	0.03
Novartis Health Care Pvt. Ltd., India	1.000000	0.03
Novartis Pharmaceuticals Corporation, United States of America (USA)	1.000000	0.03
University of Debrecen, Hungary	1.000000	0.03
Keio University, Japan	1.000000	0.03
Poznan University of Medical Sciences (PUMS), Poland	1.000000	0.03
Chaim Sheba Medical Center at Tel HaShomer, Israel	1.000000	0.03
LLC Family Clinic, Russia	1.000000	0.03
Chonnam National University Hospital (CNUH), South Korea	1.000000	0.03
Drum Tower Hospital, China	1.000000	0.03
National Institute of Global Health and Medicine, Japan	1.000000	0.03
Charité Research Organisation GmbH, Germany	1.000000	0.03
University Medical Center Freiburg, Germany	1.000000	0.03
Monash Health, Australia	0.500000	0.01
Monash University, Australia	0.500000	0.01
Semmelweis University (SE), Hungary	0.500000	0.01
Buda Hospital of the Hospitaller Order of Saint John of God, Hungary	0.500000	0.01
Chung Shan Medical University Hospital, Taiwan	0.500000	0.01
China Medical University (CMU), Taiwan	0.500000	0.01

Interested in Neurosciences?